This finding suggests that the mechanism whereby UFSHR downregulates survivin protein expression may be different from that of YM155 and its effect on survivin mRNA expression may vary slightly depending on the unique molecular actors involved in each individual’s tumor. Here, BIRC5 is linked to neoplasm.